PATENT CLAIM ANALYSIS

Application Number: 15892846
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "255050"]

Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein R 1 , R 2 , R 3 , and G are defined herein.

Claim (Index 14):
The pharmaceutical composition of  claim 9 , wherein the substituted imidazole is 3-[5-Chloro- 1-(4-fluorophenyl)-4-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)- 1H-imidazol-2-yl]-2-methoxypyridine, and enantiomers, diastereomers and pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13968480', '15202600', '13968465', '13968473', '13968470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8363256500049363
- 35 USC 102 Novelty (BERT): 0.6102595357948396
- Combined Prediction Score: 0.8137190385839266
- Mean Citation Score: 483.011248
- Max Citation Score: 584.26404
- Similarity Product: 481.65247852781306

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test